07:42 EDT Novo Nordisk (NVO) down 5% at $62.93 after CEO resignation announcement
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on NVO:
- Novo Nordisk says CEO Lars Fruergaard Jorgensen to step down
- Septerna price target raised to $18 from $11 at Wells Fargo
- Eli Lilly Stock (LLY) Falls on Reports Novo Nordisk Is Developing New Obesity Treatments
- Novo Nordisk (NVO) Signs $2.2B Deal to Develop Weight-Loss Pills
- Novo Nordisk, Septerna to collaborate to develop obesity pills
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue